| HOME >> MEDICINE >> TECHNOLOGY |
PHARMACEUTICAL INDUSTRY IN DIFFERENT COUNTRIES,
2010 23
PATENTS AND DRUG DISCOVERY TECHNOLOGY 23
PATENTS AND DRUG DISCOVERY … (CONTINUED) 24
PATENTS AND DRUG DISCOVERY … (CONTINUED) 25
TABLE 8 PATENT APPLICATION IN DRUG DISCOVERY FROM
MARCH 2012 26
TABLE 8 (CONTINUED) 27
CHAPTER FOUR: GENOMICS RESEARCH AND DRUG DISCOVERY
TECHNOLOGIES 28
OVERVIEW 28
GENOMICS STUDIES AS A PLATFORM FOR DRUG DISCOVERY
TECHNOLOGIES 29
POLYMERASE CHAIN REACTION TECHNOLOGY AS BASIS
FOR DRUG DISCOVERY 30
TABLE 9 GLOBAL REAL-TIME POLYMERASE CHAIN REACTION
MARKET, THROUGH 2017 ($ BILLIONS) 31
DNA MICROARRAYS AND DRUG DEVELOPMENT 32
DNA Microarrays and Drug Development (Continued) 33
TABLE 10 GLOBAL MARKET FOR DNA MICROARRAYS, THROUGH
2017 ($ BILLIONS) 34
RNA RESEARCH AS DRUG DISCOVERY PLATFORM FOR
NEW TECHNOLOGIES DEVELOPMENT 35
RNA Research as Drug Discovery … (Continued) 36
RNA Interference as Approach to Drug Discovery 37
TABLE 11 GLOBAL RNA INTERFERENCE MARKET, THROUGH 2017
($ MILLIONS) 38
Market Participants in the Drug Discovery Sector 38
Market Participants … (Continued) 39
NEXT-GENERATION SEQUENCING AS A TECHNOLOGY
FOR DRUG DISCOVERY RESEARCH 40
Next-Generation Sequencing … (Continued) 41
TABLE 12 GLOBAL NEXT-GENERATION SEQUENCING MARKET,
THROUGH 2017 ($ MILLIONS) 42
Next-Generation Sequencing Market Participants 43
Next-Generation … (Continued) 44
TABLE 13 NEXT-GENERATION SEQUENCING MARKET SHARES BY
COMPANY, 2012 (%) 45
EPIGENETICS APPROACH AS A PLATFORM FOR DRUG
DISCOVERY 45
DNA METHYLATION 46
HISTONE METHYLATIONS AND MODIFICATIONS 47
TABLE 14 PERCENTAGE OF COMMERCIAL KITS GENERALLY
PURCHASED FOR EPIGENETIC RESEARCH
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |